Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease
Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
StandardStandard
Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease. / Hughes, D.; Hughes, D.A.
2003. Papur a gyflwynwyd yn Welsh Health Economics Group, Cardiff, Wales, UK.
2003. Papur a gyflwynwyd yn Welsh Health Economics Group, Cardiff, Wales, UK.
Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
HarvardHarvard
Hughes, D & Hughes, DA 2003, 'Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease', Papur a gyflwynwyd yn Welsh Health Economics Group, Cardiff, Wales, UK, 3/01/01.
APA
Hughes, D., & Hughes, D. A. (2003). Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease. Papur a gyflwynwyd yn Welsh Health Economics Group, Cardiff, Wales, UK.
CBE
Hughes D, Hughes DA. 2003. Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease. Papur a gyflwynwyd yn Welsh Health Economics Group, Cardiff, Wales, UK.
MLA
Hughes, D. a D.A. Hughes Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease. Welsh Health Economics Group, Cardiff, Wales, UK, 03 Ion 0001, Papur, 2003.
VancouverVancouver
Hughes D, Hughes DA. Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease. 2003. Papur a gyflwynwyd yn Welsh Health Economics Group, Cardiff, Wales, UK.
Author
RIS
TY - CONF
T1 - Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease
AU - Hughes, D.
AU - Hughes, D.A.
PY - 2003/11/1
Y1 - 2003/11/1
M3 - Paper
T2 - Welsh Health Economics Group, Cardiff, Wales, UK
Y2 - 3 January 0001
ER -